Latest Oncopeptides News & Updates

See the latest news and media coverage for Oncopeptides. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Oncopeptides

Biotech developing therapies for hematological cancers

oncopeptides.com
Headquarters
Stockholm, Sweden
Founded year
2000
Company type
Public company
Number of employees
80–200

Last updated

Latest news about Oncopeptides

In short: Oncopeptides doubled its 2025 sales, expanded Pepaxti's commercial reach in Europe and Asia, and advanced its pipeline into glioblastoma trials.

Company announcements

Oncopeptides

Oncopeptides publishes Q1 report 2026

The quarterly report details financial results for the first quarter of 2026.

Unlock all announcements with a

Media coverage

Life Science Sweden

Kick-off for Oncopeptides' clinical study in brain cancer

The study, which is being conducted at Oslo University Hospital, will evaluate the company's proprietary platform for peptide-drug conjugates (PDC) in a total of about ten patients with glioblastoma, which is an aggressive...

Dagens industri

Oncopeptides to apply for broader indication with EMA

The biotech company Oncopeptides, which is focused on hard-to-treat cancers, intends to submit an application for a type II variation to the...

Unlock all articles with a

Never miss news about Oncopeptides

Track Oncopeptides and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.